Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study

被引:103
|
作者
Pavese, Nicola [1 ]
Rivero-Bosch, Maria [1 ]
Lewis, Stephanie J. [1 ]
Whone, Alan L. [1 ]
Brooks, David J. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Ctr Neurosci, Dept Med, London SW7 2AZ, England
基金
英国医学研究理事会;
关键词
Positron emission tomography (PET); F-18-dopa; Noradrenaline; Serotonin; Parkinson; Monoamine; Extrastriatal; POSITRON-EMISSION-TOMOGRAPHY; DOPAMINERGIC FUNCTION; LOCUS-COERULEUS; FLUORODOPA; BRAIN; HYPOTHALAMUS; LEVODOPA; DOPA; ROPINIROLE; PATHOLOGY;
D O I
10.1016/j.neuroimage.2011.03.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Post-mortem and neuroimaging studies in Parkinson's disease (PD) have shown involvement of the brain serotoninergic, noradrenergic and cholinergic pathways alongside the characteristic degeneration of nigrostriatal dopamine neurons. The rate of progression of the degenerative process in these extrastriatal areas is still unclear. We used F-18-dopa PET, a marker of aromatic aminoacid decarboxylase activity in monoaminergic neurons, to assess longitudinal changes in tracer uptake in brain noradrenergic, serotoninergic and extrastriatal dopaminergic structures over a 3-year period in a group of early PD patients. Ten PD patients had F-18-dopa PET twice: at baseline and again after 37.1 +/- 21.5 months follow up. A standard object map was used to extract tracer influx constants (Ki) in 11 striatal and extrastriatal regions. Progressive decreases in F-18-dopa Ki occurred over the follow-up period in the majority of the investigated areas, the fastest annual declines occurring in putamen (8.1%), locus coeruleus (7.8%), and globus pallidus interna (7.7%). Caudate and hypothalamus showed 6.3% and 6.1% annual Ki declines, respectively. At baseline, some structures showed increased levels of F-18-dopa uptake in PD compared to controls (internal pallidum, locus coeruleus), indicating possible compensatory upregulation of monoamine turnover. These increased levels had normalised (globus pallidus interna) or become subnormal (locus coeruleus) at follow-up suggesting exhaustion of these mechanisms within the first years of disease. Loss of monoaminergic function in extrastriatal regions, as reflected by F-18-dopa PET, is delayed and occurs independently from nigrostriatal degeneration. When assessing the efficacy of novel neuroprotective agents on nigrostriatal dysfunction in PD. F-18-dopa PET could provide supplementary information concerning function of extrastriatal monoaminergic structures. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:1463 / 1468
页数:6
相关论文
共 50 条
  • [1] Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-Dopa PET study
    Pavese, N.
    Rivero-Bosch, M.
    Lewis, S. J.
    Brooks, D. J.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S154 - S154
  • [2] The rate of progression of Parkinson's disease - A longitudinal [F-18]DOPA PET study
    Morrish, PK
    Sawle, GV
    Brooks, DJ
    [J]. PARKINSON'S DISEASE, 1996, 69 : 427 - 431
  • [3] Functional analysis of 18F-DOPA PET for the diagnosis of Parkinson's disease
    Chen, Sirong
    Leung, Yim Lung
    Cheng, Thomas
    Wong, Ka Nin
    Ho, Chi-lai
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [4] A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa:: an 18F-dopa PET study
    Rakshi, JS
    Pavese, N
    Uema, T
    Ito, K
    Morrish, PK
    Bailey, DL
    Brooks, DJ
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (12) : 1433 - 1443
  • [5] A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study
    J. S. Rakshi
    N. Pavese
    T. Uema
    K. Ito
    P. K. Morrish
    D. L. Bailey
    D. J. Brooks
    [J]. Journal of Neural Transmission, 2002, 109 : 1433 - 1443
  • [6] Progression of nigrostriatal dysfunction in a parkin kindred:: An 18F-dopa PET and clinical study
    Khan, NL
    Brooks, DJ
    Pavese, N
    Wood, NW
    Lees, AJ
    Piccini, P
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (01): : 134 - 134
  • [7] Extrastriatal monoamine neuron function in Parkinson's disease:: An 18F-dopa PET study
    Moore, Robert Y.
    Whone, Alan L.
    BrookSa, David J.
    [J]. NEUROBIOLOGY OF DISEASE, 2008, 29 (03) : 381 - 390
  • [8] 11C-PE2I and 18F-Dopa PET for Assessing Progression Rate in Parkinson's: A Longitudinal Study
    Li, Weihua
    Lao-Kaim, Nick P.
    Roussakis, Andreas A.
    Martin-Bastida, Antonio
    Valle-Guzman, Natalie
    Paul, Gesine
    Loane, Clare
    Widner, Hakan
    Politis, Marios
    Foltynie, Tom
    Barker, Roger A.
    Piccini, Paola
    [J]. MOVEMENT DISORDERS, 2018, 33 (01) : 117 - 127
  • [9] The clinical use of 18F-DOPA PET brain in the diagnosis of Parkinson's disease
    Kusmirek, Joanna
    Struck, Aaron
    Floberg, John
    Jaskowiak, Christine
    Perlman, Scott
    Hall, Lance
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [10] The rate of progression in Parkinson's disease:: A [18F]dopa PET study
    Nurmi, EM
    Ruottinen, HM
    Bergman, J
    Haaparanta, M
    Solin, O
    Rinne, JO
    [J]. NEUROLOGY, 1999, 52 (06) : A91 - A91